Related Experiment Videos
[Recurrence of Guillain-Barré syndrome]
Annales De Medecine Interne
|January 1, 1992
Summary
Some Guillain-Barré syndrome patients experience relapses, which prolong recovery and increase cerebrospinal fluid protein. These relapses worsen functional outcomes but lack predictive factors.
Area of Science:
- Neurology
- Immunology
- Clinical Medicine
Context:
- Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
- While typically monophasic, GBS can present with relapsing courses, impacting patient prognosis.
- Understanding relapse patterns is crucial for managing GBS patients.
Purpose:
- To investigate the characteristics and predictors of relapses in patients with Guillain-Barré syndrome.
- To compare the clinical course and cerebrospinal fluid findings during relapses versus initial episodes.
- To identify any factors that might predict the occurrence of relapses in GBS.
Summary:
- A study of 238 Guillain-Barré syndrome patients found that 6.3% experienced acute relapses.
- Relapses were characterized by longer plateau and recovery phases, and higher cerebrospinal fluid protein levels compared to initial episodes.
- Symptom intensity during relapses was similar to initial episodes, but functional sequelae were aggravated.
Impact:
- Relapses in Guillain-Barré syndrome can lead to prolonged recovery and increased long-term disability.
- The findings highlight the need for continued monitoring and supportive care in GBS patients, even after initial recovery.
- No specific predictive factors were identified, underscoring the unpredictable nature of GBS relapses.